Gene therapy for neuroprotection and axon regeneration in CNS injuries
Innovative gene therapy using AAV2 vectors to target Dynlt1a and Lars2 offers potential neuroprotection and axon regeneration for CNS neurons, specifically retinal ganglion cells affected by optic neuropathies. This appr...